News & Events

Latest press releases, events, presentations & media assets

Latest Press Releases

Aug 3, 2017 • 7:00am EDT

Synthetic Biologics Reports Second Quarter 2017 Operational Highlights and Financial Results

-- SYN-004 (ribaxamase) Receives Breakthrough Therapy Designation from FDA for Prevention of CDI -- -- Three Ribaxamase Presentations to be Included at Infectious Disease Week™ (ID Week) 2017 -- -- Conference Call Today, August 3, 2017, at 8:30 a.m. EDT -- ROCKVILLE, Md., Aug. 3, 2017 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, today provided an operational update and reported financial results for the three months ended June 30, 2017. ...

Read Press Release

Upcoming/Latest Events

Annual Conference on Antimicrobials and Drug Resistance

View All

Latest Publication

Gottlieb K et al. Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders. Aliment Pharmacol Ther. 2015 Nov 11.

View Publication